{
    "SPADE_N_14125": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14125",
            "Peptide Name": "NZL (NZ2114  variant 6, synthetic AMPs20a, plectasin analog, 3S=S, UCSS1a)",
            "Source": "amino acid substitution, fungal defensin analog, fungi-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GFGCNGPWSEDDIQCHNHCKSIKGYKGGYCAKGGFVCKCY",
            "Sequence Length": 40,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4361.92,
            "PI": 8.3,
            "Hydrophobicity": -0.56,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Liu H, Yang N, Teng D, Mao R, Hao Y, Ma X, Wang J.2021",
                    "Reference": "Int J Mol Sci. 2021 May 21;22(11):5435. doi: 10.3390/ijms22115435.PubMed",
                    "Title": "Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo"
                }
            ],
            "Frequent Amino Acids": "GCK",
            "Absent Amino Acids": "LMORTU",
            "Basic Residues": 7,
            "Acidic Residues": 3,
            "Hydrophobic Residues": 11,
            "Polar Residues": 23,
            "Positive Residues": 7,
            "Negative Residues": 3,
            "Net Charge": 4,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (95%) toPlectasinC: 15%, G: 20%, K: 13%.Activity: active against S. aureus ATCC 43300 or ATCC 25923 (MIC 1-4 ug/ml) and S. hyicus ACCC 61734 or NCTC 10350 (MIC 1-4 ug/ml), slightly stronger than NZ2114.Structure: CD indicates the peptide is structured in water.Recombinant production:yeast:Pichia pastoris: expressed (secreted proteins 1505 mg/L after 120 h) and purified in a 5-L fermentor.Stability: the peptide was ok 20-80oC but lost activity at 100oC; easily digested by proteases in all body fluids, but stable to pepsin and trypsin.Antimicrobial robustness: pH-insensitive (pH 2-10).Toxicity:  murine RBC: 1.11% hemolysis at 256 ug/ml: not hemo.lytic.Animal model:mouse: peritonitis  infected with S. hyicus NCTC 10350: 5 mg/kg increased survival rate to 50% (cfs: NZ2114: 33%) but the same survival rate at 10 mg/kg (83.3%).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14667",
                    "Similarity": 0.975,
                    "Sequence": "GFGCNGPWSEDDIQCHNHCKSIKGYKGGYCARGGFVCKCY"
                },
                {
                    "SPADE_ID": "SPADE_UN_22184",
                    "Similarity": 0.975,
                    "Sequence": "GFGCNGPWSEDDIQCHNHCKSIKGYKGGYCARGGFVCKCY"
                },
                {
                    "SPADE_ID": "SPADE_N_05427",
                    "Similarity": 0.95,
                    "Sequence": "GFGCNGPWDEDDMQCHNHCKSIKGYKGGYCAKGGFVCKCY"
                }
            ]
        }
    }
}